Abiopharma

New Form 4 - BRISTOL MYERS SQUIBB CO Filed: 2025-07-02 AccNo: 0000014272-25-000127 Size: 5 KB

New Form 4 - ClearPoint Neuro, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-093159 Size: 6 KB

New Form 4 - LINDE PLC Filed: 2025-07-02 AccNo: 0001707925-25-000079 Size: 8 KB

New Form 4 - Vir Biotechnology, Inc. Filed: 2025-07-02 AccNo: 0001628280-25-034055 Size: 5 KB

New Form 4 - ClearPoint Neuro, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-093154 Size: 5 KB

New Form 424B5 - ArriVent BioPharma, Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065391 Size: 636 KB

Puma Biotechnology, Inc. - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - LINDE PLC Filed: 2025-07-02 AccNo: 0001707925-25-000077 Size: 7 KB

New Form 8-K - Insight Molecular Diagnostics Inc. Filed: 2025-07-02 AccNo: 0001641172-25-017590 Size: 220 KB Item 5.07: Submission of Matters to a Vote of Security Holders

4 (Statement of Changes in Beneficial Ownership) SEC Filing

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - Modular Medical, Inc. Filed: 2025-07-02 AccNo: 0001213900-25-061072 Size: 186 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 4 - AbbVie Inc. Filed: 2025-07-02 AccNo: 0001415889-25-019106 Size: 5 KB

New Form PRE 14A - Innovative Eyewear Inc Filed: 2025-07-02 AccNo: 0001829126-25-004861 Size: 344 KB